Crispr Therapeutics shares owned by Marex Group
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Marex Group
from 13F filings
Historical chart of Marex Group investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Marex Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Marex Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $6.4M | 134k | 47.57 |
| 2025-12-31 | $6.7M | 128k | 52.50 |
| 2025-09-30 | $8.0M | 124k | 64.81 |
| 2025-06-30 | $948k | 20k | 48.64 |
| 2025-03-31 | $640k | 19k | 34.03 |
| 2024-12-31 | $943k | 24k | 39.36 |
| 2024-09-30 | $1.0M | 22k | 46.98 |
| 2024-06-30 | $1.1M | 21k | 54.01 |
| 2024-03-31 | $893k | 13k | 68.16 |
| 2023-12-31 | $818k | 13k | 62.60 |
| 2023-09-30 | $485k | 11k | 45.39 |
| 2023-06-30 | $647k | 12k | 56.14 |
| 2023-03-31 | $764k | 17k | 45.23 |
| 2022-12-31 | $400k | 9.9k | 40.65 |